Skip to main content
Published locations for Ulcerative colitis: Tofacitinib more effective than vedolizumab in patients refractory to anti-TNF
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Ulcerative colitis: Tofacitinib more effective than vedolizumab in patients refractory to anti-TNF
User login
Username
Password
Reset your password
/content/ulcerative-colitis-tofacitinib-more-effective-vedolizumab-patients-refractory-anti-tnf
/clinicianreviews/article/255873/ibd-intestinal-disorders/ulcerative-colitis-tofacitinib-more